EnobraQ
Latest round
- Series A
Last raised
- Nov 2019
Total raised
- $5.4M
Investors
- 5
About EnobraQ
Based in Toulouse, France, and founded in 2015 by Michael Kre, EnobraQ operates as a biotechnology company that develops carbon dioxide-based fermentation processes. The company's CEO is Christophe Dardel. EnobraQ develops fermentation processes to transform carbon dioxide into commodity chemicals and provides bio-based alternatives to fossil fuel-derived chemicals. The company provides solutions to the nutrition, agri-food, cosmetics, pharmacology, and bioplastics industries.
Who invested in EnobraQ
5 investors across 3 rounds
See all investors in EnobraQ
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about EnobraQ
Who invested in EnobraQ?
EnobraQ has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EnobraQ raised?
EnobraQ has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did EnobraQ last raise money?
EnobraQ's most recent round on record is a Series A, in Nov 2019.
What does EnobraQ do?
Based in Toulouse, France, and founded in 2015 by Michael Kre, EnobraQ operates as a biotechnology company that develops carbon dioxide-based fermentation processes.
Where is EnobraQ headquartered?
EnobraQ is headquartered in Toulouse, France.
Which VCs invest in companies like EnobraQ?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at EnobraQ's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like EnobraQ? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.